VanEck Biotech ETF (NASDAQ:BBH – Get Free Report) shares saw unusually-strong trading volume on Friday. Approximately 8,876 shares were traded during trading, an increase of 13% from the average daily volume of 7,824 shares. The stock last traded at $252.8930 and had previously closed at $251.01.
VanEck Biotech ETF Price Performance
The company has a 50-day moving average price of $242.11 and a 200-day moving average price of $208.06.
Hedge Funds Weigh In On VanEck Biotech ETF
Institutional investors have recently modified their holdings of the company. Nwam LLC purchased a new stake in VanEck Biotech ETF during the second quarter valued at about $18,614,000. Quantitative Investment Management LLC acquired a new position in VanEck Biotech ETF during the 2nd quarter worth approximately $7,589,000. Bank of America Corp DE boosted its holdings in VanEck Biotech ETF by 44.3% in the 1st quarter. Bank of America Corp DE now owns 66,338 shares of the company’s stock worth $12,473,000 after acquiring an additional 20,375 shares during the period. Ascent Advisors LLC acquired a new position in shares of VanEck Biotech ETF during the first quarter worth $11,178,000. Finally, Proficio Capital Partners LLC acquired a new position in VanEck Biotech ETF in the 2nd quarter worth $5,183,000. Institutional investors and hedge funds own 32.05% of the company’s stock.
VanEck Biotech ETF Company Profile
The BIOTECH HOLDING COMPANY DEPOSITARY RECEIPTS or HOLDRS TRUST was formed under the depositary trust agreement, among The Bank of New York, as trustee, Merrill Lynch, Pierce, Fenner & Smith Incorporated, other depositors and the owners of the Biotech HOLDRS. The trust currently holds shares of common stock or American depositary shares issued by a group of companies that were, at the time of the initial offering, generally considered to be involved in various segments of thebiotechnology industry.
Further Reading
- Five stocks we like better than VanEck Biotech ETF
- Array and Shoals Are Merging: Who Really Wins the All-Stock Solar Deal?
- Duolingo’s User Growth Is Outpacing Bookings, But Is Its Strategy Paying Off?
- Block by Block: Cash App Builds a Stronger Foundation
- Arista Networks Cashes In on the AI Infrastructure Buildout
Receive News & Ratings for VanEck Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for VanEck Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
